MONTREAL, Jan. 31 /PRNewswire-FirstCall/ - CryoCath Technologies , the global leader in cryotherapy products to treat cardiovascular disease, will be holding its annual meeting, hosted by Henri Vienneau, Interim Chief Executive Officer and Chairman of the Board of Directors and Mr. Derek Lindsay, Chief Financial Officer.
DATE: Tuesday, February 20, 2007 TIME: 4:30 p.m., Eastern Standard Time LOCATION: Hotel InterContinental Maissoneuve Room 360 Sainte Antoine Street Ouest (West) Montreal, Quebec, Canada About CryoCath
CryoCath - www.cryocath.com - is a medical technology company that leads the world in cryotherapy products to treat cardiovascular disease. With a priority focus on providing physicians with a complete solution of catheter and surgical products to treat cardiac arrhythmias, CryoCath has multiple products approved in the U.S., across Europe and several ROW countries. The Company is developing additional products to expand its pipeline of products to treat cardiac arrhythmias.
This press release includes "forward-looking statements" that are subject to risks and uncertainties, including with respect to the timing of regulatory trials and their outcome. For information identifying legislative or regulatory, economic, climatic, currency, technological, competitive and other important factors that could cause actual results to differ materially from those anticipated in the forward looking statements, see CryoCath's annual report available at www.sedar.com under the heading Risks and Uncertainties in the Management's Discussion and Analysis section.
CryoCath Technologies Inc.CONTACT: visit our website at www.cryocath.com, or contact: Michael Moore,Investor Relations, Phone: (416) 815-0700 ext. 241, Fax: (416) 815-0080,E-mail: mmoore@equicomgroup.com